Literature DB >> 7623376

Chaperonins can catalyse the reversal of early aggregation steps when a protein misfolds.

N A Ranson1, N J Dunster, S G Burston, A R Clarke.   

Abstract

Chaperonins use energy derived from ATP hydrolysis to enhance the efficiency of protein folding by a mechanism which remains a matter of debate. Here, we show that the kinetics of spontaneous and assisted folding of mitochondrial malate dehydrogenase are quantitatively described by a simple physical model. The protein folds from non-native chains by the slow formation of native-like monomers, which then dimerize to form the active enzyme. Misfolding proceeds by two phases of aggregation: the first is slowly reversible, the second is irreversible. Chaperonins accelerate the dissociation of the first-formed, unstable aggregates through a repeated binding-and-release cycle coupled to ATP hydrolysis. By this catalytic action, they supply the productive folding pathway with monomers, and block the irreversible phase of aggregation, thereby maintaining optimal folding yields even when present in sub-stoichiometric quantities. The hydrolytically active chaperonin is required until the substrate protein has completed the slow transition to its native-like, monomeric state. Both the observed rate of folding and the yield are increased by this mechanism without changing real rates in the productive pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7623376     DOI: 10.1006/jmbi.1995.0399

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  32 in total

Review 1.  Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions.

Authors:  Arthur Horwich
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Folding with and without encapsulation by cis- and trans-only GroEL-GroES complexes.

Authors:  George W Farr; Wayne A Fenton; Tapan K Chaudhuri; Daniel K Clare; Helen R Saibil; Arthur L Horwich
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

3.  Substrate polypeptide presents a load on the apical domains of the chaperonin GroEL.

Authors:  Fumihiro Motojima; Charu Chaudhry; Wayne A Fenton; George W Farr; Arthur L Horwich
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-12       Impact factor: 11.205

4.  Expansion and compression of a protein folding intermediate by GroEL.

Authors:  Zong Lin; Hays S Rye
Journal:  Mol Cell       Date:  2004-10-08       Impact factor: 17.970

5.  Significance of chaperonin 10-mediated inhibition of ATP hydrolysis by chaperonin 60.

Authors:  Y Dubaquié; R Looser; S Rospert
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

6.  Direct NMR observation of a substrate protein bound to the chaperonin GroEL.

Authors:  Reto Horst; Eric B Bertelsen; Jocelyne Fiaux; Gerhard Wider; Arthur L Horwich; Kurt Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

7.  Interaction of the N-terminal domain of Escherichia coli heat-shock protein ClpB and protein aggregates during chaperone activity.

Authors:  Naoki Tanaka; Yasushi Tani; Hiroyuki Hattori; Tomoko Tada; Shigeru Kunugi
Journal:  Protein Sci       Date:  2004-11-10       Impact factor: 6.725

Review 8.  GroEL-mediated protein folding: making the impossible, possible.

Authors:  Zong Lin; Hays S Rye
Journal:  Crit Rev Biochem Mol Biol       Date:  2006 Jul-Aug       Impact factor: 8.250

9.  Mimicking the action of GroEL in molecular dynamics simulations: application to the refinement of protein structures.

Authors:  Hao Fan; Alan E Mark
Journal:  Protein Sci       Date:  2006-02-01       Impact factor: 6.725

10.  Probing the sequence of conformationally induced polarity changes in the molecular chaperonin GroEL with fluorescence spectroscopy.

Authors:  So Yeon Kim; Alexander N Semyonov; Robert J Twieg; Arthur L Horwich; Judith Frydman; W E Moerner
Journal:  J Phys Chem B       Date:  2005-12-29       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.